These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 21852944)

  • 1. Structure and dynamics of the membrane-bound cytochrome P450 2C9.
    Cojocaru V; Balali-Mood K; Sansom MS; Wade RC
    PLoS Comput Biol; 2011 Aug; 7(8):e1002152. PubMed ID: 21852944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiresolution molecular dynamics simulations reveal the interplay between conformational variability and functional interactions in membrane-bound cytochrome P450 2B4.
    Han SB; Teuffel J; Mukherjee G; Wade RC
    Protein Sci; 2024 Oct; 33(10):e5165. PubMed ID: 39291728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple, ligand-dependent routes from the active site of cytochrome P450 2C9.
    Cojocaru V; Winn PJ; Wade RC
    Curr Drug Metab; 2012 Feb; 13(2):143-54. PubMed ID: 22208529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flexibility of human cytochrome P450 enzymes: molecular dynamics and spectroscopy reveal important function-related variations.
    Hendrychová T; Anzenbacherová E; Hudeček J; Skopalík J; Lange R; Hildebrandt P; Otyepka M; Anzenbacher P
    Biochim Biophys Acta; 2011 Jan; 1814(1):58-68. PubMed ID: 20656072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Membrane position of ibuprofen agrees with suggested access path entrance to cytochrome P450 2C9 active site.
    Berka K; Hendrychová T; Anzenbacher P; Otyepka M
    J Phys Chem A; 2011 Oct; 115(41):11248-55. PubMed ID: 21744854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavior of human cytochromes P450 on lipid membranes.
    Berka K; Paloncýová M; Anzenbacher P; Otyepka M
    J Phys Chem B; 2013 Oct; 117(39):11556-64. PubMed ID: 23987570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intramolecular heme ligation of the cytochrome P450 2C9 R108H mutant demonstrates pronounced conformational flexibility of the B-C loop region: implications for substrate binding.
    Roberts AG; Cheesman MJ; Primak A; Bowman MK; Atkins WM; Rettie AE
    Biochemistry; 2010 Oct; 49(40):8700-8. PubMed ID: 20815369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differing Membrane Interactions of Two Highly Similar Drug-Metabolizing Cytochrome P450 Isoforms: CYP 2C9 and CYP 2C19.
    Mustafa G; Nandekar PP; Bruce NJ; Wade RC
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31487853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural and energetic analysis to provide insight residues of CYP2C9, 2C11 and 2E1 involved in valproic acid dehydrogenation selectivity.
    Bello M; Mendieta-Wejebe JE; Correa-Basurto J
    Biochem Pharmacol; 2014 Jul; 90(2):145-58. PubMed ID: 24794636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The structure of human cytochrome P450 2C9 complexed with flurbiprofen at 2.0-A resolution.
    Wester MR; Yano JK; Schoch GA; Yang C; Griffin KJ; Stout CD; Johnson EF
    J Biol Chem; 2004 Aug; 279(34):35630-7. PubMed ID: 15181000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flexibility of human cytochromes P450: molecular dynamics reveals differences between CYPs 3A4, 2C9, and 2A6, which correlate with their substrate preferences.
    Skopalík J; Anzenbacher P; Otyepka M
    J Phys Chem B; 2008 Jul; 112(27):8165-73. PubMed ID: 18598011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploration of the binding of proton pump inhibitors to human P450 2C9 based on docking and molecular dynamics simulation.
    Shi R; Li J; Cao X; Zhu X; Lu X
    J Mol Model; 2011 Aug; 17(8):1941-51. PubMed ID: 21120554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of Transmembrane Helix Mutations on Cytochrome P450-Membrane Interactions and Function.
    Mustafa G; Nandekar PP; Camp TJ; Bruce NJ; Gregory MC; Sligar SG; Wade RC
    Biophys J; 2019 Feb; 116(3):419-432. PubMed ID: 30658838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights into the structural features and functional relevance of human cytochrome P450 2C9. Part II.
    Mo SL; Zhou ZW; Yang LP; Wei MQ; Zhou SF
    Curr Drug Metab; 2009 Dec; 10(10):1127-50. PubMed ID: 20167000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amphipol-facilitated elucidation of the functional tetrameric complex of full-length cytochrome P450 CYP2B4 and NADPH-cytochrome P450 oxidoreductase.
    Cheng S; Bo Z; Hollenberg P; Osawa Y; Zhang H
    J Biol Chem; 2021; 296():100645. PubMed ID: 33839156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformational diversity and ligand tunnels of mammalian cytochrome P450s.
    Yu X; Cojocaru V; Wade RC
    Biotechnol Appl Biochem; 2013; 60(1):134-45. PubMed ID: 23587001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Site of metabolism prediction on cytochrome P450 2C9: a knowledge-based docking approach.
    Tarcsay A; Kiss R; Keseru GM
    J Comput Aided Mol Des; 2010 May; 24(5):399-408. PubMed ID: 20361237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation, characterization, and substrate metabolism of gold-immobilized cytochrome P450 2C9.
    Gannett PM; Kabulski J; Perez FA; Liu Z; Lederman D; Locuson CW; Ayscue RR; Thomsen NM; Tracy TS
    J Am Chem Soc; 2006 Jul; 128(26):8374-5. PubMed ID: 16802783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substrate selectivity of human cytochrome P450 2C9: importance of residues 476, 365, and 114 in recognition of diclofenac and sulfaphenazole and in mechanism-based inactivation by tienilic acid.
    Melet A; Assrir N; Jean P; Pilar Lopez-Garcia M; Marques-Soares C; Jaouen M; Dansette PM; Sari MA; Mansuy D
    Arch Biochem Biophys; 2003 Jan; 409(1):80-91. PubMed ID: 12464247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure of microsomal cytochrome P450 2B4 complexed with the antifungal drug bifonazole: insight into P450 conformational plasticity and membrane interaction.
    Zhao Y; White MA; Muralidhara BK; Sun L; Halpert JR; Stout CD
    J Biol Chem; 2006 Mar; 281(9):5973-81. PubMed ID: 16373351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.